RA Capital

TORL BioTherapeutics

torlbio.com

Torl biotherapeutics is building a preeminent biopharmaceutical company dedicated to the discovery, development, and commercialization of antibody-based therapies to improve and extend the lives of people with cancer worldwide. Through a strategic partnership with the slamon research lab at ucla, torl has exclusive development and commercial rights to a large program of biologics-based drugs for promising, and novel cancer targets.